Drugs Made In America Acquisition II Corp. (DMIIU) Assets (2024 - 2025)
Drugs Made In America Acquisition (DMIIU) posted quarterly Assets of $505.0 million for Q4 2025, up 365643.31% year-over-year from N/an in Q4 2024, and up 0.79% quarter-over-quarter from $501.0 million in Q3 2025.
Drugs Made In America Acquisition II Corp. (DMIIU) Assets (2024 - 2025) Analysis & Trends
Drugs Made In America Acquisition (DMIIU) has reported Assets for 2 consecutive years, with $505.0 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Assets rose 365643.31% year-over-year to $505.0 million; the TTM figure through Dec 2025 stood at $505.0 million (up 365643.31% YoY), while the FY2025 annual figure was $505.0 million, up 365643.31% from the prior year.
- Assets advanced to $505.0 million in Q4 2025 per DMIIU's latest filing, from $501.0 million in the prior quarter.
- Across five years, Assets topped out at $505.0 million in Q4 2025 and bottomed at $138064.0 in Q4 2024.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 504.96 Mn |
| Sep 30, 2025 | 501.01 Mn |
| Dec 31, 2024 | 138,064.00 |